What Is the Ozempic Blindness Lawsuit About?

The Ozempic blindness lawsuit alleges that Novo Nordisk failed to warn users of the diabetes drug’s link to vision issues, including blindness caused by nonarteritic anterior ischemic optic neuropathy (NAION).

Studies suggest semaglutide, Ozempic’s active ingredient, may cause optic nerve damage. If you’ve experienced sudden vision changes after using Ozempic, you might be entitled to compensation for your medical expenses and related damages.

ContactUptown Injury Law, PLLC, Ozempic vision loss attorneys at 917-540-8728 to get a free case review.

What Are the Core Claims in Ozempic Blindness Lawsuit?

Ozempic blindness lawsuits claim that Novo Nordisk failed to adequately warn patients about the risk of vision loss caused by nonarteritic anterior ischemic optic neuropathy (NAION), a condition that can lead to sudden and permanent blindness.

In addition to NAION, semaglutide, the active ingredient in Ozempic, has been linked to other vision-related side effects such as:

• Diabetic retinopathy
• Eye strokes
• Macular complications

TheseOzempic lawsuits highlight how vision loss severely impacts the lives of victims, causing financial instability, difficulty performing everyday tasks, and the inability to work. For many, the consequences extend beyond physical health risks, affecting their mental well-being, relationships, and overall quality of life.

Ozempic Blindness Lawsuit 2024 Updates

Ozempic blindness lawsuits continue to grow in 2024, with more people claiming that Novo Nordisk failed to warn them about the risk of vision loss caused by the drug.

September 16, 2024: Growing Concerns Over Vision Loss and Ozempic

The American Association of Ophthalmology has raised alarms about the risks associated with Ozempic and other GLP-1 drugs, suggesting they may cause blindness or vision loss through conditions like diabetic retinopathy and eye strokes.

The most concerning issue is NAION, which can result in sudden, irreversible vision loss in one eye. This growing concern over Ozempic’s impact on eye health has made vision loss a central issue in ongoing lawsuits.

July 14, 2024: Latest Studies Link Ozempic to Increased Risk of Vision Loss

A July 2024 study found that Ozempic users are at higher risk for developing NAION, a condition that can cause permanent blindness.

This adds to earlier research, including a 2020 study that identified over 140 vision-related side effects from semaglutide, the active ingredient in Ozempic. These findings strengthen the case for people filing lawsuits over severe vision loss.

July 2024: Blindness Concerns Escalate as Ozempic Use Increases

Following new studies, concerns about blindness linked to Ozempic have strengthened. The recent findings suggest that Ozempic users are at a higher risk of experiencing sudden and often permanent vision loss.

Many are questioning why Novo Nordisk has not more prominently warned patients about these risks, as similar concerns about other side effects like stomach paralysis have also been raised.

January 2024: Eye Risks from Ozempic Under Scrutiny

A routine review of semaglutide patients in early 2024 revealed significant eye-related risks. Among the most common were blurred vision, diabetic retinopathy, and other macular complications.

The review has sparked calls for further research to better understand the full scope of vision risks associated with Ozempic use. Many legal experts anticipate these findings will play a significant role in the ongoing Ozempic vision loss lawsuits.

August 2021: Diabetic Retinopathy Risk Heightened by Ozempic Use

Research from 2021 indicates that Ozempic may increase the risk of diabetic retinopathy (DR), particularly for patients with pre-existing DR.

The study suggests that quick changes in blood sugar levels due to Ozempic can exacerbate DR complications, putting users at greater risk of vision loss. This link further underscores the potential dangers of Ozempic for diabetic patients, adding to the concerns raised in lawsuits.

June 2020: Early Findings Indicate Increased Eye Risks with Ozempic

An initial study published in 2020 revealed that Ozempic users experienced higher rates of diabetic retinopathy and other ocular issues compared to those using other GLP-1 receptor agonists.

The study reported a 16.4% rate of diabetic retinopathy among Ozempic users, significantly higher than the rates for other similar medications.

What Is Ozempic, and What Are Its Common Side Effects?

Ozempic is a medication mainly used to manage Type 2 diabetes by regulating blood sugar levels. It belongs to a class of drugs called GLP-1 receptor agonists, which work by mimicking a hormone that boosts insulin production after meals and slows glucose release from the liver. This helps improve blood sugar levels.

In recent years, Ozempic has also gained popularity as a treatment for weight loss, as it helps reduce appetite and food intake. While Ozempic is effective for blood sugar control and weight management, it has several side effects. The most commonly noted side effects are gastrointestinal, including:

• Nausea
• Vomiting
• Diarrhea
• Constipation
• Other possible side effects include dizziness, fatigue, and headaches

More severe but rare side effects include vision loss, mainly due to NAION. This condition occurs when a blood vessel feeding the optic nerve is blocked, leading to vision loss and sometimes blindness. A 2024 study in JAMA Ophthalmology highlighted that patients taking Ozempic had a significantly higher risk of developing NAION compared to those not using a GLP-1 agonist.

Additionally, the FDA is investigating potential links between Ozempic and side effects like hair loss and suicidal thoughts. Although no definitive connection has been established, the FDA continues to monitor these concerns.

“As of November 2024, gastrointestinal issues remain the most frequently reported side effects, with nausea being the most common complaint.”

How Does Ozempic Cause Blindness and Vision Loss?

Ozempic works by regulating blood sugar, but sudden changes in blood sugar level can harm the eyes, causing blurry vision and damage to the retina. Also, people with diabetes are already more likely to have eye problems like diabetic retinopathy, which can get worse with Ozempic use.

Another issue is hypoglycemia (low blood sugar), which can change the shape of the eye’s lens, leading to blurry vision. Ozempic may also interact with other semaglutide medications, increasing the risk of vision issues. Ozempic’s side effects on the eyes may include:

• Sudden vision loss in one eye (mild to severe)
• Blurred or unclear vision
• Color distortion 
• Light sensitivity
• Dark spots or shadows in your vision
• Loss of peripheral (side) vision
• Swelling of the optic disc

These vision problems can significantly impact quality of life, making it essential for users to be aware of these potential risks. If you experience any vision changes while using Ozempic, call us at 917-540-8728for a free case evaluation.

Mass Eye and Ear Study Highlights Vision Problems With Ozempic

A study from Mass Eye and Ear, a Harvard-affiliated hospital, analyzed data from over 16,000 patients and found 37 cases of NAION after starting semaglutide (Ozempic). The research found that:

“Patients taking semaglutide for weight loss were seven times more likely to develop NAION compared to those on other weight loss treatments. While the study does not prove a direct cause-and-effect link, the findings suggest a significant association that warrants further investigation.”

How Many People Reported Blindness From Ozempic?

Research involving 710 patients using semaglutide for Type 2 diabetes and obesity revealed the following:

• 8.9% of diabetic patients on semaglutide developed NAION, compared to 1.8% on other diabetes medications.
• 6.7% of patients using semaglutide for obesity treatment reported NAION versus just 0.8% on other weight loss drugs.

These statistics highlight a significant increase in blindness risk among Ozempic users, prompting further investigation into the drug’s safety.

Novo Nordisk Statement on NAION Vision Loss Claims 

Novo Nordisk has denied claims linking Ozempic (semaglutide) to vision loss or non-arteritic anterior ischemic optic neuropathy (NAION). The company argues that the current data is not strong enough to prove a connection between the drug and the condition.

A representative from Novo Nordisk pointed out that NAION is not listed as a side effect of semaglutide on the drug’s label. They also criticized the Mass Eye and Ear study for its small, non-randomized sample size, which makes the findings unreliable.

The company highlighted that patient safety is their top priority, and they seriously consider every report of adverse events related to their medications. However, they claim that there is insufficient evidence to link semaglutide with NAION.

How to File an Ozempic Blindness Lawsuit?

To file an Ozempic blindness lawsuit, start by consulting an experienced attorney who can evaluate your case and determine your eligibility. An attorney will guide you through the process, helping you gather evidence and file your claim within the required timeframe. Acting quickly, make sure you don’t miss important deadlines that could affect your case. Here’s a quick guide to filing your lawsuit:

Consult With an Experienced Attorney

The first step is to consult a lawyer experienced in Ozempic litigation. They will evaluate your case, review the evidence, and determine your eligibility to file an Ozempic lawsuit. Your attorney will also explain the filing deadlines, ensuring your claim is submitted on time.

Gather Evidence

To support your lawsuit, you’ll need to gather evidence that proves you were prescribed Ozempic and developed non-arteritic anterior ischemic optic neuropathy (NAION) or other vision issues. This includes medical records, prescriptions, test results, and any documentation showing the link between Ozempic and your vision problems.

Formally File Your Claim

Your attorney will handle the legal process on your behalf. This includes filing your lawsuit with the appropriate court and working to build a strong case. Be available for any additional information or documentation your attorney may need to strengthen your claim.

Settlement or Trial

In some cases, your attorney may present you with an opportunity to settle out of court. If afair settlement is reached, you will get compensation for medical treatment expenses, lost wages, and other damages. However, if a settlement isn’t agreed upon, your case will go to trial, where a judge/jury will determine the outcome.

What Compensation Can You Expect in Ozempic Blindness Lawsuits?

In the Ozempic blindness lawsuit, you may be eligible for compensation to cover medical expenses, lost wages, pain and suffering, and emotional distress caused by your vision loss.

The amount you could receive depends on the severity of your condition, how it has impacted your daily life, and the strength of the evidence supporting your case.

In some instances, settlements can range from hundreds of thousands to millions of dollars, helping you cover ongoing medical costs, rehabilitation, and other related expenses.

Speak With Our Ozempic Attorneys for a Free Case Review

If you or a loved one has suffered vision loss or blindness after taking Ozempic, we understand the challenges you’re facing. At Uptown Injury Law, PLLC, we’re here to listen to your story, answer your concerns, and help you understand your legal options—without any obligation or cost to you.

With 15+ years of experience and a history of securing multi-million dollar settlements in New York, our dedicated law team is ready to fight for the compensation you deserve.

We offer a free,no-obligation consultation to review your case, and we work on a contingency fee basis—meaning you don’t pay unless we win. You’ve already been through enough, and we’re here to make the legal process as easy and stress-free as possible.

Reach out to us today at 917-540-8728 to schedule your FREE OF COST consultation.

FAQs